Cargando…
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
BACKGROUND: Treatment success rates of multidrug-resistant tuberculosis (MDR-TB) remain unsatisfactory, and long-term use of second-line anti-TB drugs is accompanied by the frequent occurrence of adverse events, low treatment compliance, and high costs. The development of new efficient regimens with...
Autores principales: | Lee, Myungsun, Mok, Jeongha, Kim, Deog Kyeom, Shim, Tae Sun, Koh, Won-Jung, Jeon, Doosoo, Lee, Taehoon, Lee, Seung Heon, Kim, Ju Sang, Park, Jae Seuk, Lee, Ji Yeon, Kim, Song Yee, Lee, Jae Ho, Jo, Kyung-Wook, Jhun, Byung Woo, Kang, Young Ae, Ahn, Joong Hyun, Kim, Chang-Ki, Shin, Soyoun, Song, Taeksun, Shin, Sung Jae, Kim, Young Ran, Ahn, Heejung, Hahn, Seokyung, Won, Ho Jeong, Jang, Ji Yeon, Cho, Sang Nae, Yim, Jae-Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335682/ https://www.ncbi.nlm.nih.gov/pubmed/30651149 http://dx.doi.org/10.1186/s13063-018-3053-1 |
Ejemplares similares
-
TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3β pathway and activation of caspases
por: Seo, Suk-Bin, et al.
Publicado: (2010) -
Six-Month Response to Delamanid Treatment in MDR TB Patients
por: Hewison, Cathy, et al.
Publicado: (2017) -
‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012) -
Effect of MDR1 gene polymorphisms on mortality in paraquat intoxicated patients
por: Kim, Hak Jae, et al.
Publicado: (2016) -
The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis
por: Kwon, Byoung Soo, et al.
Publicado: (2020)